… in the United States to minimize the risk of cervical cancer. We evaluated … screening with
a Pap test and human papillomavirus (HPV) testing is useful for assessing the risk for cervical …

… Baseline cytology, human papillomavirus testing, and risk for cervical neoplasia: a 10-year …
Chapter 13: primary screening of cervical cancer with human papillomavirus tests. J Natl …

… human papillomavirus (HPV)–based cervical screening will be introduced in the Netherlands
in 2016. We assessed the 5-year cervical (pre)cancer risk of … cytology triaged by baseline …

… testing at KPNC between 2003 and 2005. We also assessed the risk of cervical cancer after
the second screening … HPV=human papillomavirus test. ASC-US=atypical squamous-cells of …

… An analysis among younger women also being HC2-positive 2 years before baseline showed
a subsequent 10-year risk of ≥CIN3 of 18% (14.6–21.5). Among older women where HPV …

… We previously published a report on 10-year risk using this … the risk for CIN2+ and CIN3+
after any baseline result for each … at risk (ie, who had undergone routine cytology screening) …

… either human papillomavirus test had a very low risk of CIN2+ (<0.3%) compared with CIN2+
risk in … adjunctive methods with Pap cytology for improving detection of cervical neoplasia. …

… human papillomavirus (HPV) test for cervical cancer … when using primary HPV testing
compared with cytology, even when … through provincial screening) post-baseline HPV testing were …

… of human papillomavirus (HPV) testing in cervical cancer … history related to cervical cancer
screening in past 10 year was … ≥ 25 years with baseline cytology and HR-HPV testing and 3-…

… of women who test Pap-negative, but human papillomavirus (… [ 12 ] to estimate risks over
time strictly after the baseline test, … When risk was calculated for a cytology result without regard …